Logo image of VPT.CA

VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Stock Fundamental Analysis

TSX-V:VPT - TSX Venture Exchange - CA92281P2008 - Common Stock - Currency: CAD

0.135  +0.01 (+3.85%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VPT. VPT was compared to 15 industry peers in the Health Care Equipment & Supplies industry. VPT has a bad profitability rating. Also its financial health evaluation is rather negative. VPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year VPT has reported negative net income.
VPT had a negative operating cash flow in the past year.
In the past 5 years VPT always reported negative net income.
In the past 5 years VPT always reported negative operating cash flow.
VPT.CA Yearly Net Income VS EBIT VS OCF VS FCFVPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

VPT has a Return On Assets of -529.04%. This is amonst the worse of the industry: VPT underperforms 80.00% of its industry peers.
Industry RankSector Rank
ROA -529.04%
ROE N/A
ROIC N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPT.CA Yearly ROA, ROE, ROICVPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

VPT has a Gross Margin (57.18%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of VPT has grown nicely.
The Profit Margin and Operating Margin are not available for VPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
VPT.CA Yearly Profit, Operating, Gross MarginsVPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

VPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VPT has been increased compared to 1 year ago.
VPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VPT is higher compared to a year ago.
VPT.CA Yearly Shares OutstandingVPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VPT.CA Yearly Total Debt VS Total AssetsVPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

VPT has an Altman-Z score of -112.00. This is a bad value and indicates that VPT is not financially healthy and even has some risk of bankruptcy.
VPT's Altman-Z score of -112.00 is on the low side compared to the rest of the industry. VPT is outperformed by 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -112
ROIC/WACCN/A
WACC7.56%
VPT.CA Yearly LT Debt VS Equity VS FCFVPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

2.3 Liquidity

VPT has a Current Ratio of 0.17. This is a bad value and indicates that VPT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of VPT (0.17) is worse than 80.00% of its industry peers.
A Quick Ratio of 0.17 indicates that VPT may have some problems paying its short term obligations.
VPT has a Quick ratio of 0.17. This is in the lower half of the industry: VPT underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
VPT.CA Yearly Current Assets VS Current LiabilitesVPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

VPT shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.33%.
The Revenue has grown by 267.55% in the past year. This is a very strong growth!
VPT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.28% yearly.
EPS 1Y (TTM)2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.37%
Revenue 1Y (TTM)267.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPT.CA Yearly Revenue VS EstimatesVPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 50K 100K 150K 200K 250K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VPT.CA Price Earnings VS Forward Price EarningsVPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPT.CA Per share dataVPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENTRIPOINT DIAGNOSTICS LTD

TSX-V:VPT (6/27/2025, 7:00:00 PM)

0.135

+0.01 (+3.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-03 2025-06-03
Earnings (Next)08-27 2025-08-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.11%
Ins Owner ChangeN/A
Market Cap22.03M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 132.32
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -529.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.18%
FCFM N/A
ROA(3y)-362.62%
ROA(5y)-271.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y16.84%
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -112
F-Score4
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)267.55%
Revenue growth 3YN/A
Revenue growth 5Y3.28%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.05%
OCF growth 3YN/A
OCF growth 5YN/A